These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 24709882

  • 1. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R, Zhang W, Wang T, He X, Huang Z, Zhu J, Yao Z.
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [Abstract] [Full Text] [Related]

  • 2. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC, Wei JJ, Wang F, Chen MT, Zhang MZ.
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [Abstract] [Full Text] [Related]

  • 3. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris.
    Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T.
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):161-7. PubMed ID: 17095712
    [Abstract] [Full Text] [Related]

  • 4. Extracellular ubiquitin levels are increased in coronary heart disease and associated with the severity of the disease.
    Ji Y, Yao J, Zhao Y, Zhai J, Weng Z, He Y.
    Scand J Clin Lab Invest; 2020 May; 80(3):256-264. PubMed ID: 32077763
    [Abstract] [Full Text] [Related]

  • 5. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM, Armstrong PW, Califf RM, Johnston N, Simoons ML, Venge P, James SK.
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [Abstract] [Full Text] [Related]

  • 6. [Pentraxin 3].
    Inoue K.
    Rinsho Byori; 2011 Jul; 59(7):694-701. PubMed ID: 21874796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S, Ikeda S, Yoshida T, Nakata T, Takeno M, Masuda N, Koide Y, Kawano H, Maemura K.
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [Abstract] [Full Text] [Related]

  • 9. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting.
    Saygı S, Kırılmaz B, Tengiz İ, Türk UÖ, Yıldız H, Tuzun N, Alioğlu E, Tamer GS, Ercan E.
    Turk Kardiyol Dern Ars; 2012 Apr; 40(3):205-12. PubMed ID: 22864315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
    Kume N, Mitsuoka H, Hayashida K, Tanaka M.
    J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
    [Abstract] [Full Text] [Related]

  • 12. Characterization of interleukin-33 and matrix metalloproteinase-28 in serum and their association with disease severity in patients with coronary heart disease.
    Liu CL, Shen DL, Zhu K, Tang JN, Wang XF, Zhang L, Zhang JY.
    Coron Artery Dis; 2014 Sep; 25(6):498-504. PubMed ID: 24710352
    [Abstract] [Full Text] [Related]

  • 13. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N, Zhang JY, Yang SZ, Li YD.
    J Biol Regul Homeost Agents; 2015 Sep; 29(2):437-41. PubMed ID: 26122234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
    Qiang H, Zhou ZX, Ma AQ, Cheng H, Zhou P.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.
    Dongming L, Zuxun L, Liangjie X, Biao W, Ping Y.
    Clin Chim Acta; 2010 Mar; 411(5-6):406-10. PubMed ID: 20026323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA, Heiba NM, Abdelmageed WM.
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [Abstract] [Full Text] [Related]

  • 20. [Circulating cytokine measurements by protein chips in patients with acute coronary syndrome].
    Mao H, Liu TZ, Wen M, Chen JJ, Li L, Zhu JK.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):219-22. PubMed ID: 19099977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.